What Fueled The Previous Growth In The Female Fertility And Pregnancy Rapid Test Market?
The female fertility and pregnancy rapid test market has seen considerable growth due to a variety of factors.
• Over the years, the market for female fertility and pregnancy rapid tests has seen substantial growth. It is projected to increase from $1.4 billion in 2024 to $1.49 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.1%. Various factors contributed to this growth in the past, including heightened awareness about reproductive health, postponement of childbearing age due to societal and cultural shifts, increase in maternal age, and over-the-counter availability.
What Can Be Expected from the Female Fertility And Pregnancy Rapid Test Market Size?
The Female Fertility And Pregnancy Rapid Test market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the market size for female fertility and pregnancy rapid tests is set to experience robust growth. The projected growth will take the market size to $1.96 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%.
Several factors are attributing to this growth in the forecast period, such as personalized medicine tactics, increased interest in natural family planning, worldwide fertility tourism, as well as family planning campaigns and affordable healthcare attempts by the government. Some of the emerging trends for this forecast period are the integration of digital health, adopting telemedicine, fostering partnerships, and collaborations within the healthcare industry, the rise of online retail sources for selling test kits, and breakthroughs in ovulation prediction tests.
What Are the Critical Driver Fuelling The Female Fertility And Pregnancy Rapid Test Market's Growth?
A rise in gynecological health conditions is anticipated to fuel the expansion of the female fertility and pregnancy quick test market. Gynecological disorders pertain to health issues that impact the female reproductive system, including the breasts, and abdominal and pelvic organs like the uterus, ovaries, vagina, fallopian tubes, and vulva. Fertility evaluations can be conducted to confirm ovulation and/or to determine infertility conditions, characterized as the inability to conceive naturally, aiding in lowering the rate of gynecological health issues. For example, a study released in July 2022 by the National Library of Medicine, a medical library based in the US, suggested that the commonality of gynecological disorders includes dispensable uterine fibroids (14.23%), spontaneous abortion (13.20%), ovarian dysfunction (11.16%), endometriosis (4.09%), polycystic ovary syndrome (19.04%), and dysmenorrhea (45.96%). Hence, the escalating rate of gynecological disorders is steering the growth of the female fertility and pregnancy quick test market.
How Is The Female Fertility And Pregnancy Rapid Test Market segmented?
The female fertility and pregnancy rapid test market covered in this report is segmented –
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits
2) By Device Type: Digital Devices, Line-indicator Devices
3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test
4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel
Subsegments:
1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits
2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests
Pre-Book The Female Fertility And Pregnancy Rapid Test Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Female Fertility And Pregnancy Rapid Test Market?
Innovations in products have emerged as a significant trend within the female fertility and pregnancy rapid test market. To maintain their competitive edge, leading firms are producing inventive testing kits. For instance, Salignostics, an Israel-based research and development company specialized in creating saliva-based rapid diagnostic assays, introduced Salistick, a saliva-based pregnancy test, in November 2022. Salistick, which has an improved user interface and high precision in detecting early pregnancy, is the first of its kind. This test kit utilises the company's revolutionary technology to detect the pregnancy hormone HCG in saliva. Those taking the test place one part of the kit in their mouth for several seconds to gather saliva, then place it in a testing tube, and results are available in under 10 minutes.
Who Are the Key Players In The Female Fertility And Pregnancy Rapid Test Market?
Major companies operating in the female fertility and pregnancy rapid test market include:
• Abbott Laboratories
• Atlas Medical GmbH
• bioMérieux SA
• Church & Dwight Co. Inc.
• Quidel Corporation
• Egens Group
• Eurofins Scientific SE
• Everlywell Inc.
• Genea Pty Limited
• Geratherm Medical AG
• SA Scientific Ltd.
• Artron Laboratories Inc.
• PRIMA Lab SA
• The Procter & Gamble Company
• Alere Inc.
• Prestige Brands Holdings Inc.
• SPD Swiss Precision Diagnostics GmbH
• Fairhaven Health LLC
• Fertility Focus Limited
• HiLin Life Products Inc.
• Inverness Medical Innovations Inc.
• UEBE Medical GmbH
• Wondfo Biotech Co. Ltd.
What Is The Most Dominant Region In The Female Fertility And Pregnancy Rapid Test Market?
North America was the largest region in the female fertility and pregnancy rapid test market in 2024. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
